TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice

Valeria Conte, Ramesh Raghupathi, Deborah J. Watson, Scott Fujimoto, Nicolas C. Royo, Niklas Marklund, Nino Stocchetti, Tracy K. McIntosh

Research output: Contribution to journalArticle

Abstract

Purpose: The ability of brain-derived neurotrophic factor (BDNF) to attenuate secondary damage and influence behavioral outcome after experimental traumatic brain injury (TBI) remains controversial. Because TBI can result in decreased expression of the trkB receptor, thereby preventing BDNF from exerting potential neuroprotective effects, the contribution of both BDNF and its receptor trkB to hippocampal neuronal loss and cognitive dysfunction were evaluated. Methods: Full-length trkB was overexpressed in the left hippocampus of adult C57Bl/6 mice using recombinant adeno-associated virus serotype 2/5 (rAAV 2/5). EGFP (enhanced green fluorescent protein) expression was present at two weeks after AAV-EGFP injection and remained sustained up to four weeks after the injection. At 2 weeks following gene transduction, mice were subjected to parasagittal controlled cortical impact (CCI) brain injury, followed by either BDNF or PBS infusion into the hippocampus. Results: No differences were observed in learning ability at two weeks post-injury or in motor function from 48 hours to two weeks among treatment groups. The number of surviving pyramidal neurons in the CA2-CA3 region of the hippocampus was also not different among treatment groups. Conclusions: These data suggest that neither overexpression of trkB, BNDF infusion or their combination affects neuronal survival or behavioral outcome following experimental TBI in mice.

Original languageEnglish
Pages (from-to)45-56
Number of pages12
JournalRestorative Neurology and Neuroscience
Volume26
Issue number1
Publication statusPublished - 2008

Fingerprint

Brain-Derived Neurotrophic Factor
trkB Receptor
Hippocampus
Aptitude
Genes
Dependovirus
Injections
Pyramidal Cells
Neuroprotective Agents
Brain Injuries
Learning
Wounds and Injuries
Therapeutics
Traumatic Brain Injury
enhanced green fluorescent protein

Keywords

  • Adeno-associated virus
  • Cell death
  • Cognition
  • In vivo gene therapy
  • Neurotrophins

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Conte, V., Raghupathi, R., Watson, D. J., Fujimoto, S., Royo, N. C., Marklund, N., ... McIntosh, T. K. (2008). TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice. Restorative Neurology and Neuroscience, 26(1), 45-56.

TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice. / Conte, Valeria; Raghupathi, Ramesh; Watson, Deborah J.; Fujimoto, Scott; Royo, Nicolas C.; Marklund, Niklas; Stocchetti, Nino; McIntosh, Tracy K.

In: Restorative Neurology and Neuroscience, Vol. 26, No. 1, 2008, p. 45-56.

Research output: Contribution to journalArticle

Conte, Valeria ; Raghupathi, Ramesh ; Watson, Deborah J. ; Fujimoto, Scott ; Royo, Nicolas C. ; Marklund, Niklas ; Stocchetti, Nino ; McIntosh, Tracy K. / TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice. In: Restorative Neurology and Neuroscience. 2008 ; Vol. 26, No. 1. pp. 45-56.
@article{6fcb2d19e0084492beb4a026c165327b,
title = "TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice",
abstract = "Purpose: The ability of brain-derived neurotrophic factor (BDNF) to attenuate secondary damage and influence behavioral outcome after experimental traumatic brain injury (TBI) remains controversial. Because TBI can result in decreased expression of the trkB receptor, thereby preventing BDNF from exerting potential neuroprotective effects, the contribution of both BDNF and its receptor trkB to hippocampal neuronal loss and cognitive dysfunction were evaluated. Methods: Full-length trkB was overexpressed in the left hippocampus of adult C57Bl/6 mice using recombinant adeno-associated virus serotype 2/5 (rAAV 2/5). EGFP (enhanced green fluorescent protein) expression was present at two weeks after AAV-EGFP injection and remained sustained up to four weeks after the injection. At 2 weeks following gene transduction, mice were subjected to parasagittal controlled cortical impact (CCI) brain injury, followed by either BDNF or PBS infusion into the hippocampus. Results: No differences were observed in learning ability at two weeks post-injury or in motor function from 48 hours to two weeks among treatment groups. The number of surviving pyramidal neurons in the CA2-CA3 region of the hippocampus was also not different among treatment groups. Conclusions: These data suggest that neither overexpression of trkB, BNDF infusion or their combination affects neuronal survival or behavioral outcome following experimental TBI in mice.",
keywords = "Adeno-associated virus, Cell death, Cognition, In vivo gene therapy, Neurotrophins",
author = "Valeria Conte and Ramesh Raghupathi and Watson, {Deborah J.} and Scott Fujimoto and Royo, {Nicolas C.} and Niklas Marklund and Nino Stocchetti and McIntosh, {Tracy K.}",
year = "2008",
language = "English",
volume = "26",
pages = "45--56",
journal = "Restorative Neurology and Neuroscience",
issn = "0922-6028",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice

AU - Conte, Valeria

AU - Raghupathi, Ramesh

AU - Watson, Deborah J.

AU - Fujimoto, Scott

AU - Royo, Nicolas C.

AU - Marklund, Niklas

AU - Stocchetti, Nino

AU - McIntosh, Tracy K.

PY - 2008

Y1 - 2008

N2 - Purpose: The ability of brain-derived neurotrophic factor (BDNF) to attenuate secondary damage and influence behavioral outcome after experimental traumatic brain injury (TBI) remains controversial. Because TBI can result in decreased expression of the trkB receptor, thereby preventing BDNF from exerting potential neuroprotective effects, the contribution of both BDNF and its receptor trkB to hippocampal neuronal loss and cognitive dysfunction were evaluated. Methods: Full-length trkB was overexpressed in the left hippocampus of adult C57Bl/6 mice using recombinant adeno-associated virus serotype 2/5 (rAAV 2/5). EGFP (enhanced green fluorescent protein) expression was present at two weeks after AAV-EGFP injection and remained sustained up to four weeks after the injection. At 2 weeks following gene transduction, mice were subjected to parasagittal controlled cortical impact (CCI) brain injury, followed by either BDNF or PBS infusion into the hippocampus. Results: No differences were observed in learning ability at two weeks post-injury or in motor function from 48 hours to two weeks among treatment groups. The number of surviving pyramidal neurons in the CA2-CA3 region of the hippocampus was also not different among treatment groups. Conclusions: These data suggest that neither overexpression of trkB, BNDF infusion or their combination affects neuronal survival or behavioral outcome following experimental TBI in mice.

AB - Purpose: The ability of brain-derived neurotrophic factor (BDNF) to attenuate secondary damage and influence behavioral outcome after experimental traumatic brain injury (TBI) remains controversial. Because TBI can result in decreased expression of the trkB receptor, thereby preventing BDNF from exerting potential neuroprotective effects, the contribution of both BDNF and its receptor trkB to hippocampal neuronal loss and cognitive dysfunction were evaluated. Methods: Full-length trkB was overexpressed in the left hippocampus of adult C57Bl/6 mice using recombinant adeno-associated virus serotype 2/5 (rAAV 2/5). EGFP (enhanced green fluorescent protein) expression was present at two weeks after AAV-EGFP injection and remained sustained up to four weeks after the injection. At 2 weeks following gene transduction, mice were subjected to parasagittal controlled cortical impact (CCI) brain injury, followed by either BDNF or PBS infusion into the hippocampus. Results: No differences were observed in learning ability at two weeks post-injury or in motor function from 48 hours to two weeks among treatment groups. The number of surviving pyramidal neurons in the CA2-CA3 region of the hippocampus was also not different among treatment groups. Conclusions: These data suggest that neither overexpression of trkB, BNDF infusion or their combination affects neuronal survival or behavioral outcome following experimental TBI in mice.

KW - Adeno-associated virus

KW - Cell death

KW - Cognition

KW - In vivo gene therapy

KW - Neurotrophins

UR - http://www.scopus.com/inward/record.url?scp=43249085575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249085575&partnerID=8YFLogxK

M3 - Article

C2 - 18431005

AN - SCOPUS:43249085575

VL - 26

SP - 45

EP - 56

JO - Restorative Neurology and Neuroscience

JF - Restorative Neurology and Neuroscience

SN - 0922-6028

IS - 1

ER -